About: Comparison of confirmed COVID‐19 with SARS and MERS cases ‐ Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta‐analysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of confirmed COVID‐19 with SARS and MERS cases ‐ Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta‐analysis Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Comparison of confirmed COVID‐19 with SARS and MERS cases ‐ Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta‐analysis
Creator	Raymond, \| Turner, J Turner, Raymond Bahr, C Behzad Baradaran, \| Farzi, Rana Ghorbani, Saied Idrovo, Juan-Pablo Khatami, Alireza Nathan, \| Pormohammad, Ali Turner, Diana
Source	Medline; PMC
abstract	INTRODUCTION: Within this large‐scale study, we compared clinical symptoms, laboratory findings, radiographic signs, and outcomes of COVID‐19, SARS, and MERS to find unique features. METHOD: We searched all relevant literature published up to February 28, 2020. Depending on the heterogeneity test, we used either random or fixed‐effect models to analyze the appropriateness of the pooled results. Study has been registered in the PROSPERO database (ID 176106). RESULT: Overall 114 articles included in this study; 52 251 COVID‐19 confirmed patients (20 studies), 10 037 SARS (51 studies), and 8139 MERS patients (43 studies) were included. The most common symptom was fever; COVID‐19 (85.6%, P < .001), SARS (96%, P < .001), and MERS (74%, P < .001), respectively. Analysis showed that 84% of Covid‐19 patients, 86% of SARS patients, and 74.7% of MERS patients had an abnormal chest X‐ray. The mortality rate in COVID‐19 (5.6%, P < .001) was lower than SARS (13%, P < .001) and MERS (35%, P < .001) between all confirmed patients. CONCLUSIONS: At the time of submission, the mortality rate in COVID‐19 confirmed cases is lower than in SARS‐ and MERS‐infected patients. Clinical outcomes and findings would be biased by reporting only confirmed cases, and this should be considered when interpreting the data.
has issue date	2020-06-05(xsd:dateTime)
bibo:doi	10.1002/rmv.2112
bibo:pmid	32502331
has license	no-cc
sha1sum (hex)	a91dc34b3d4bca0bcbdf8218864a239f5551e4c3
schema:url	https://doi.org/10.1002/rmv.2112
resource representing a document's title	Comparison of confirmed COVID‐19 with SARS and MERS cases ‐ Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta‐analysis
has PubMed Central identifier	PMC7300470
has PubMed identifier	32502331
schema:publication	Rev Med Virol
resource representing a document's body	covid:a91dc34b3d4bca0bcbdf8218864a239f5551e4c3#body_text
is schema:about of	named entity 'COMPARED' named entity 'radiographic' named entity 'clinical symptoms' named entity 'SARS' named entity 'unique features' named entity 'COVID' named entity 'MERS' named entity 'COVID' named entity 'Thomson Reuters' named entity '95% CI' named entity 'New York' named entity 'Middle East Respiratory Syndrome Coronavirus' named entity 'SARS' named entity 'Inflammation' named entity 'SARS' named entity 'coronavirus' named entity 'funnel plot' named entity 'case reports' named entity 'asymptomatic' named entity '2019-nCoV' named entity 'Englewood, NJ' named entity 'Publication bias' named entity 'Google scholar' named entity 'protein' named entity 'global health' named entity 'SARS' named entity 'COVID-19' named entity 'SARS' named entity 'COVID-19' named entity 'PRISMA' named entity 'Wuhan' named entity 'Severe Acute Respiratory Syndrome' named entity '95% CI' named entity 'Fever' named entity 'runny nose' named entity 'early diagnosis' named entity 'mortality rate' named entity 'COVID-19' named entity 'pathogenic viruses' named entity 'SARS' named entity 'titer' named entity 'Wuhan' named entity 'chi-squared test' named entity 'EndNote' named entity 'leukopenia' named entity 'random effect' named entity 'Wuhan' named entity 'CDC' named entity 'risk factor' named entity 'meta-analysis' named entity 'Web of Science' named entity 'COVID-19' named entity 'google.com' named entity 'MERS' named entity 'demographic' named entity '95% CI' named entity 'cytokines' named entity 'SARS' named entity 'case reports' named entity 'Coronavirus' named entity 'Cough' named entity 'publication bias' named entity 'Scopus' named entity 'cytokine storm' named entity 'MeSH' named entity 'clinical symptoms' named entity 'COVID-19' named entity 'MERS' named entity 'China' named entity 'radiographic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software